Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cipla
Covington
Queensland Health
Boehringer Ingelheim
Federal Trade Commission
Chubb
Farmers Insurance
Dow

Generated: May 26, 2018

DrugPatentWatch Database Preview

A-N STANNOUS AGGREGATED ALBUMIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do A-n Stannous Aggregated Albumin patents expire, and when can generic versions of A-n Stannous Aggregated Albumin launch?

A-n Stannous Aggregated Albumin is a drug marketed by Syncor Pharms and is included in one NDA.

The generic ingredient in A-N STANNOUS AGGREGATED ALBUMIN is technetium tc-99m albumin aggregated kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m albumin aggregated kit profile page.
Summary for A-N STANNOUS AGGREGATED ALBUMIN
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 864
DailyMed Link:A-N STANNOUS AGGREGATED ALBUMIN at DailyMed
Drug patent expirations by year for A-N STANNOUS AGGREGATED ALBUMIN

US Patents and Regulatory Information for A-N STANNOUS AGGREGATED ALBUMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Syncor Pharms A-N STANNOUS AGGREGATED ALBUMIN technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017916-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Argus Health
Julphar
US Department of Justice
Baxter
UBS
McKinsey
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.